Xiangjun Kong
Associate Director @ AstraZeneca
About
I am applying genetic engineering techniques and genetic screening approaches for the treatment of human cancer.
Netherlands
Amsterdam
Biotechnology
Cancer Biology, Tumor immunology, Molecular Biology, Genetic Engineering, Immunology, Cancer, Molecular Genetics, Bioinformatics, Biochemistry, Cell Biology, Genetics, Genetic Screening
Experience
Associate Director
AstraZeneca
Amsterdam, North Holland, Netherlands
Neogene Therapeutics is now a part of the AstraZeneca Group.
Principal Scientist
Neogene Therapeutics
Amsterdam, North Holland, Netherlands
Senior Scientist
Neogene Therapeutics
Scientist
Neogene Therapeutics
Amsterdam Area, Netherlands
Postdoctoral Fellow
The Netherlands Cancer Institute
Using high-throughput genetic screening approaches to study mechanisms of cancer drug addiction and cancer immunotherapy resistance. * Applying whole genome CRISPR/Cas9 screening to identify key players mediating cancer drug addiction. * Wrote and successfully co-applied a KWF research grant to study cancer drug resistance and drug addiction mechanisms, managed the project.
Education
University of Science and Technology of China
Cell/Cellular and Molecular Biology
Anhui Agricultural University
Tea science
Xiangjun Kong's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.